紫杉醇PLGA纳米粒的表征及体外抗肿瘤作用研究
x

请在关注微信后,向客服人员索取文件

篇名: 紫杉醇PLGA纳米粒的表征及体外抗肿瘤作用研究
TITLE: Characterization of paclitaxel-PLGA nanoparticles and their antitumor effects in vitro
摘要: 目的 表征紫杉醇纳米粒(PTX-PLGA-NPs),并评价其对Lewis肺癌细胞的体外抑制作用。方法对以乳化溶剂挥发法所制PTX-PLGA-NPs的粒径、多分散性指数(PDI)、Zeta电位、微观形态、包封率、载药量、紫外-可见光吸收特性、稳定性等进行表征;以小鼠Lewis肺癌细胞为对象,以PTX对照品为参照,分别采用CCK-8法、Calcein-AM/PI双染法检测PTX-PLGA-NPs的细胞毒性和体外杀伤活性,分别采用AnnexinⅤ-FITC/PI染色法、PI染色法评估PTX-PLGA-NPs对细胞凋亡及周期的影响。结果PTX-PLGA-NPs呈类球形,平均粒径为(172.03±0.95)nm,PDI为0.098±0.012,Zeta电位为(-1.76±0.02)mV;包封率和载药量分别为(52.32±0.66)%、(7.07±0.18)%,紫外-可见光吸收特征不受载体聚乳酸-羟基乙酸共聚物的影响;4℃下避光放置7d时,其粒径无明显变化,平均PDI(放置1、2、4、7d)均小于0.3。与PTX对照品组相比,PTX-PLGA-NPs组有更多细胞处于死亡状态,其存活率(当PTX质量浓度为11.2μg/mL时)显著降低,凋亡率和G2期细胞比例均显著升高(P<0.05)。结论所制PTX-PLGA-NPs粒径均一、分散均匀、性质稳定,对肺癌细胞的体外杀伤作用较PTX强。
ABSTRACT: OBJECTIVE To characterize paclitaxel nanoparticles (PTX-PLGA-NPs) and evaluate their in vitro inhibitory effect on Lewis lung cancer cells. METHODS The PTX-PLGA-NPs prepared by the emulsion-solvent evaporation method were characterized in terms of particle size, polydispersity index (PDI), Zeta potential, microscopic morphology, encapsulation efficiency, drug loading, ultraviolet-visible absorption characteristics and stability. Using mouse Lewis lung cancer cells as the subjects and paclitaxel reference substance as the control, the cytotoxicity and in vitro killing activity of PTX-PLGA-NPs were detected using CCK-8 method and Calcein-AM/PI double staining method, respectively. The effects of PTX-PLGA-NPs on cell apoptosis and cell cycle were assessed by Annexin Ⅴ-FITC/PI staining method and PI staining method, respectively. RESULTS PTX-PLGA-NPs were spherical with an average particle size of (172.03±0.95) nm, PDI of 0.098±0.012, and Zeta potential of (-1.76±0.02) mV. The encapsulation efficiency and drug loading were (52.32±0.66)% and (7.07±0.18)%, respectively, and the ultraviolet-visible absorption characteristics were not affected by the carrier polylactic-co-glycolic acid. When stored in the dark at 4 °C for 7 days, no significant change was noted in particle size, and the average PDI (after 1, 2, 4 and 7 days of storage) was under 0.3. Compared with the paclitaxel reference substance group, the PTX-PLGA-NPs group had more cells in a state of death, the survival rate (at the PTX concentration of 11.2 μg/mL) was significantly decreased, and both the apoptosis rate and the proportion of G2 phase cells were significantly increased (P<0.05). CONCLUSIONS The prepared PTX-PLGA-NPs indicate homogeneity in particle size, uniform dispersion, stable properties, and stronger in vitro killing effect on lung cancer cells than PTX.
期刊: 2024年第35卷第22期
作者: 王晓静;郭子硕;张海桐;陈宛灵;李加玲;杜守颖;李鹏跃
AUTHORS: WANG Xiaojing,GUO Zishuo,ZHANG Haitong,CHEN Wanling,LI Jialing,DU Shouying,LI Pengyue
关键字: 紫杉醇;聚乳酸-羟基乙酸共聚物;纳米粒;表征;Lewis肺癌细胞;体外抗肿瘤作用
KEYWORDS: paclitaxel; polylactic-co-glycolic acid; nanoparticles; characteristics; Lewis lung cancer cells; antitumor effects in vitro
阅读数: 6 次
本月下载数: 1 次

* 注:未经本站明确许可,任何网站不得非法盗链资源下载连接及抄袭本站原创内容资源!在此感谢您的支持与合作!